Order Code | Test Name |
---|
N/A | Unusually resistant or atypical sensitivity patterns- Supplemental testing may be performed (test code dependent on method used).
- Agar diffusion method, per plate.
- Microtiter MIC method.
- Referral to a Reference Laboratory for Broth Dilution or confirmatory testing.
|
---|
N/A | Unusual or difficult identifications- Supplemental testing may be performed (test code dependent on method used).
- Bacterial ID by DNA Sequencing.
- Referral to a Reference Laboratory (dependent on whether isolate is a bacteria, yeast, mold or AFB).
|
---|
93 | Lower Resp Tract Culture w/ Gram Stain- If growth present, pathogens are identified and sensitivities done on each pathogen. All IDs and sensitivities are charged; workups limited to six isolates.
- ID test code per isolate.
- If unable to identify isolate, identification by 16S rRNA sequencing is performed.
- If isolate identified as Staph aureus, and patient is an inpatient, an “MRSA, Rapid Test” may be done; dependent on sufficient growth.
- Sensitivity test code per isolate (dependent on method used):
Agar Dilution method Disk method Microtiter MIC method - If Staph aureus sensitivity shows Erythromycin Resistant/Clindamycin Sensitive pattern, a “D-Test for Clindamycin Resistance” is done (Disk method).
|
---|
308 | Vibrio Stool Culture- If growth suspicious for Vibrio is present, identification is done and charged if growth is identified as Vibrio sp.
- ID test code per isolate.
|
---|
311 | Yersinia Stool Culture - If growth suspicious for Yersinia is present, identification is done and charged if growth is identified as Yersinia sp.
- ID test code per isolate.
|
---|
616 | Throat Culture- If beta strep present, further identification is done and charged.
- ID test code per isolate.
|
---|
618 | MRSA Culture Screen- If growth suspicious for Staph species is present, identification is done and charged if growth is identified as Methicillin Resistant Staph Aureus.
- ID test code per isolate.
|
---|
619 | Blood Culture- All growth is identified and charged. Sensitivities are charged on all growth for which susceptibility testing standards are available.
- ID test code per isolate.
- ID test code per anaerobic isolate.
- If unable to identify isolate, identification by 16S rRNA sequencing is performed.
- If isolate identified as Staph aureus, an “MRSA, Rapid Test” may be done; dependent on sufficient growth.
- Sensitivity test code per isolate (dependent on method used):
Agar Dilution method Disk method Microtiter MIC method - If Staph aureus sensitivity shows Erythromycin Resistant/Clindamycin Sensitive pattern, a “D-Test for Clindamycin Resistance” is done (Disk method).
|
---|
620 | CSF Culture & Gram Stain- All growth is identified and charged. Sensitivities are charged on all growth for which susceptibility testing standards are available.
- ID test code per isolate.
- ID test code per anaerobic isolate.
- If unable to identify isolate, identification by 16S rRNA sequencing is performed.
- If isolate identified as Staph aureus, and patient is an inpatient, an “MRSA, Rapid Test” may be done; dependent on sufficient growth.
- Sensitivity test code per isolate (dependent on method used):
Agar Dilution method Disk method Microtiter MIC method - If Staph aureus sensitivity shows Erythromycin Resistant/Clindamycin Sensitive pattern, a “D-Test for Clindamycin Resistance” is done (Disk method).
|
---|
621 | Anaerobic Culture- If growth present, identifications are done and charged on all anaerobic isolates.
- ID test code per isolate.
|
---|
622 | Stool Culture w/ Shiga Toxin- If growth suspicious for Salmonella, Shigella, Campylobacter, or E. coli 0157 is present, identification is done and charged if growth is identified as a stool pathogen.
- ID test code per isolate.
|
---|
624 | Miscellaneous Culture- If growth present, identifications are done and charged according to source type. Sensitivities are done and charged on pathogens. (Work-ups limited to three isolates.)
- ID test code per isolate.
- ID test code per anaerobic isolate.
- If unable to identify isolate and from a critical source, identification by 16S rRNA sequencing is performed.
- If isolate identified as Staph aureus, and patient is an inpatient, an “MRSA, Rapid Test” may be done; dependent on sufficient growth.
- Sensitivity test code per isolate (dependent on method used):
Agar Dilution method Disk method Microtiter MIC method - If Staph aureus sensitivity shows Erythromycin Resistant/Clindamycin Sensitive pattern, a “D-Test for Clindamycin Resistance” is done (Disk method).
|
---|
625 | GC Screen- If growth suspicious for GC is present, identification is done and charged if growth is identified as GC.
- ID test code per isolate.
|
---|
626 | Urine Culture- If growth present, identifications are done on predominant and/or significant organisms and sensitivities are also done if these organisms are pathogens. All IDs and sensitivities are charged.
- ID test code per isolate.
- If isolate identified as Staph aureus, and patient is an inpatient, an “MRSA, Rapid Test” may be done; dependent on sufficient growth.
- Sensitivity test code per isolate (dependent on method used):
Agar Dilution method Disk method Microtiter MIC method - If Staph aureus sensitivity shows Erythromycin Resistant/Clindamycin Sensitive pattern, a “D-Test for Clindamycin Resistance” is done (Disk method).
|
---|
626C | Cath Urine Culture- If growth present, identifications are done on predominant and/or significant organisms and sensitivities are also done if these organisms are pathogens. All IDs and sensitivities are charged.
- ID test code per isolate.
- If isolate identified as Staph aureus, and patient is an inpatient, an “MRSA, Rapid Test” may be done; dependent on sufficient growth.
- Sensitivity test code per isolate (dependent on method used):
Agar Dilution method Disk method Microtiter MIC method - If Staph aureus sensitivity shows Erythromycin Resistant/Clindamycin Sensitive pattern, a “D-Test for Clindamycin Resistance” is done (Disk method).
|
---|
639 | Organism ID/Sensitivity, Aerobic- If growth present, identifications are done and charged according to source type. Sensitivities are done and charged on pathogens; workups limited to three isolates. Culture itself is not charged as these are submitted as pre-cultured specimens, but a handling fee will be assessed if mixed isolates are received.
- ID test code per isolate.
- If unable to identify isolate and from a critical source, identification by 16S rRNA sequencing is performed.
- If isolate identified as Staph aureus, and patient is an inpatient, an “MRSA, Rapid Test” may be done; dependent on sufficient growth.
- Sensitivity test code per isolate (dependent on method used):
Agar Dilution method Disk method Microtiter MIC method - If Staph aureus sensitivity shows Erythromycin Resistant/Clindamycin Sensitive pattern, a “D-Test for Clindamycin Resistance” is done (Disk method).
|
---|
645 | Fungus Culture- All fungal isolates are identified and charged.
- ID test code per isolate, yeast.
- ID test code per isolate, mold.
- Dimorphic fungi (e.g. C. immitis, Blastomyces, Histoplasma) are sent to a reference lab for confirmatory testing and identification.
|
---|
646 | AFB Blood/Bone Marrow If growth is isolated, further testing is done as follows:- TB DNA probe is done.
- If TB DNA probe is positive, TB sensitivity is done. NOTE: sensitivity is charged for each of 4 drugs tested.
- If TB sensitivity is resistant to 1 drug:
Isolate is referred to reference lab for single drug MIC testing. If drug is Rifampin, isolate is referred to reference lab for secondary drug panel. If drug is PZA, isolate is referred to reference lab for Mycobacterial MIC testing. - If TB sensitivity is resistant to 2 or more drugs:
Isolate is referred to reference lab for primary drug panel. If isolate is resistant to Rifampin, isolate is also referred for a secondary drug panel. - If TB DNA probe is negative, MALDI-TOF identification is done.
- If identification by MALDI-TOF is acceptable, sample referred to reference lab for sensitivity testing.
- If identification by MALDI-TOF is unacceptable, sample referred to reference lab for further ID/sensitivity testing.
|
---|
651 | Acid Fast Smear and Culture If growth is isolated, further testing done as follows:- TB DNA probe is done.
- If TB DNA probe is positive, TB sensitivity is done. NOTE: sensitivity is charged for each of 4 drugs tested.
- If TB sensitivity is resistant to 1 drug:
Isolate is referred to reference lab for single drug MIC testing. If drug is Rifampin, isolate is referred to reference lab for secondary drug panel. If drug is PZA, isolate is referred to reference lab for Mycobacterial MIC testing. - If TB sensitivity is resistant to 2 or more drugs:
Isolate is referred to reference lab for primary drug panel. If isolate is resistant to Rifampin, isolate is also referred for a secondary drug panel. - If TB DNA probe is negative, MALDI-TOF identification is done.
- If identification by MALDI-TOF is acceptable, sample referred to reference lab for sensitivity testing.
- If identification by MALDI-TOF is unacceptable, sample referred to reference lab for further ID/sensitivity testing.
|
---|
661 | VRE Culture Screen- If growth suspicious for Enterococcus is present, identification is done and charged if growth is identified as Vancomycin Resistant Enterococcus.
- ID test code per isolate.
|
---|
4105 | Bone Marrow Culture- All growth is identified and charged. Sensitivities are charged on all growth for which susceptibility testing standards are available.
- ID test code per isolate.
- If unable to identify isolate, identification by 16S rRNA sequencing is performed.
- If isolate identified as Staph aureus, and patient is an inpatient, an “MRSA, Rapid Test” may be done; dependent on sufficient growth.
- Sensitivity test code per isolate (dependent on method used):
Agar Dilution method Disk method Microtiter MIC method - If Staph aureus sensitivity shows Erythromycin Resistant/Clindamycin Sensitive pattern, a “D-Test for Clindamycin Resistance” is done (Disk method).
|
---|
4106 | Catheter Tip Culture- If growth present, identifications are done and charged on all isolates. Sensitivities are done and charged on all pathogens and non-pathogens showing a significant colony count; workups limited to six isolates.
- ID test code per isolate.
- If unable to identify isolate, identification by 16S rRNA sequencing is performed.
- If isolate identified as Staph aureus, and patient is an inpatient, an “MRSA, Rapid Test” may be done; dependent on sufficient growth.
- Sensitivity test code per isolate (dependent on method used):
Agar Dilution method Disk method Microtiter MIC method - If Staph aureus sensitivity shows Erythromycin Resistant/Clindamycin Sensitive pattern, a “D-Test for Clindamycin Resistance” is done (Disk method).
|
---|
4533 | Organism ID – Fungal- All fungal isolates are identified and charged. Culture itself is not charged as these are submitted as pre-cultured specimens, but a handling fee will be assessed if mixed isolates are received
- ID test code per isolate, yeast.
- ID test code per isolate, mold.
- Dimorphic fungi (e.g. C. immitis, Blastomyces, Histoplasma) are sent to a reference lab for confirmatory testing and identification.
|
---|
4534 | Organism ID – AFB- All mycobacterial isolates are identified and charged. Culture itself is not charged as these are submitted as pre-cultured specimens, but a handling fee will be assessed if mixed isolates are received.
- If growth is isolated, further testing is done as follows:
- TB DNA probe is done.
- If TB DNA probe is positive, TB sensitivity is done. NOTE: sensitivity is charged for each of 4 drugs tested.
- If TB sensitivity is resistant to 1 drug:
Isolate is referred to reference lab for single drug MIC testing. If drug is Rifampin, isolate is referred to reference lab for secondary drug panel. If drug is PZA, isolate is referred to reference lab for Mycobacterial MIC testing. - If TB sensitivity is resistant to 2 or more drugs:
Isolate is referred to reference lab for primary drug panel. If isolate is resistant to Rifampin, isolate is also referred for a secondary drug panel. - If TB DNA probe is negative, MALDI-TOF identification is done.
- If identification by MALDI-TOF is acceptable, sample referred to reference lab for sensitivity testing.
- If identification by MALDI-TOF is unacceptable, sample referred to reference lab for further ID/sensitivity testing.
|
---|
4535 | Organism ID – Anaerobic- All anaerobic isolates are identified and charged. Culture itself is not charged as these are submitted as pre-cultured specimens, but a handling fee will be assessed if mixed isolates are received.
- ID test code per isolate.
- If unable to identify isolate, identification by 16S rRNA sequencing is performed.
|
---|
5512 | Genital Culture- If growth present, identifications are done and charged according to source type. Sensitivities are done and charged on pathogens in significant numbers. (Work-ups limited to three isolates.)
- ID test code per isolate.
- If unable to identify isolate, identification by 16S rRNA sequencing may be performed.
- If isolate identified as Staph aureus, and patient is an inpatient, an “MRSA, Rapid Test” may be done; dependent on sufficient growth.
- Sensitivity test code per isolate (dependent on method used):
Agar Dilution method Disk method Microtiter MIC method - If Staph aureus sensitivity shows Erythromycin Resistant/Clindamycin Sensitive pattern, a “D-Test for Clindamycin Resistance” is done (Disk method).
|
---|
5519 | Abscess Culture- If growth present, identifications are done and charged according to source type. Sensitivities are done and charged on pathogens. (Work-ups limited to three isolates.)
- ID test code per isolate.
- If unable to identify isolate, identification by 16S rRNA sequencing may be performed.
- If isolate identified as Staph aureus, and patient is an inpatient, an “MRSA, Rapid Test” may be done; dependent on sufficient growth.
- Sensitivity test code per isolate (dependent on method used):
Agar Dilution method Disk method Microtiter MIC method - If Staph aureus sensitivity shows Erythromycin Resistant/Clindamycin Sensitive pattern, a “D-Test for Clindamycin Resistance” is done (Disk method).
|
---|
5521 | Aspirate Culture- If growth present, identifications are done and charged according to source type. Sensitivities are done and charged on pathogens. (Work-ups limited to three isolates.)
- ID test code per isolate.
- If unable to identify isolate, identification by 16S rRNA sequencing may be performed.
- If isolate identified as Staph aureus, and patient is an inpatient, an “MRSA, Rapid Test” may be done; dependent on sufficient growth.
- Sensitivity test code per isolate (dependent on method used):
Agar Dilution method Disk method Microtiter MIC method - If Staph aureus sensitivity shows Erythromycin Resistant/Clindamycin Sensitive pattern, a “D-Test for Clindamycin Resistance” is done (Disk method).
|
---|
5535 | Wound Culture- If growth present, identifications are done and charged according to source type. Sensitivities are done and charged on pathogens. (Work-ups limited to three isolates.)
- ID test code per isolate.
- If unable to identify isolate, identification by 16S rRNA sequencing may be performed.
- If isolate identified as Staph aureus, and patient is an inpatient, an “MRSA, Rapid Test” may be done; dependent on sufficient growth.
- Sensitivity test code per isolate (dependent on method used):
Agar Dilution method Disk method Microtiter MIC method - If Staph aureus sensitivity shows Erythromycin Resistant/Clindamycin Sensitive pattern, a “D-Test for Clindamycin Resistance” is done (Disk method).
|
---|
5631 | Stool Culture for Aeromonas species- If growth suspicious for Aeromonas species is present, identification is done and charged if confirmed as Aeromonas.
- ID test code per isolate.
- If unable to identify isolate, identification by 16S rRNA sequencing may be performed.
|
---|
5823 | Prostatitis Culture- If growth present, identifications are done on all organisms with colony counts >1,000 organisms/ml and sensitivities are also done if these organisms are pathogens. All IDs and sensitivities are charged.
- ID test code per isolate.
- If unable to identify isolate, identification by 16S rRNA sequencing may be performed.
- If isolate identified as Staph aureus, and patient is an inpatient, an “MRSA, Rapid Test” may be done; dependent on sufficient growth.
- Sensitivity test code per isolate (dependent on method used):
Agar Dilution method Disk method Microtiter MIC method - If Staph aureus sensitivity shows Erythromycin Resistant/Clindamycin Sensitive pattern, a “D-Test for Clindamycin Resistance” is done (Disk method).
|
---|
6204R | GBS Screen, DNA NAAT w/Reflex Sensi- If GBS Screen is positive, a no charge culture for isolation of GBS for susceptibility testing by Microtiter MIC method is performed.
|
---|
6233 | Fungus Culture, Hair/Nail/Skin- All fungal isolates are identified and charged.
- ID test code per isolate, yeast.
- ID test code per isolate, mold.
- Dimorphic fungi (e.g. C. immitis, Blastomyces, Histoplasma) are sent to a reference lab for confirmatory testing and identification.
|
---|
7123 | C difficile GDH/Toxin reflex NAAT If GDH/Toxin results are discrepant (neg/pos or pos/neg), C.difficile NAAT molecular test is performed. |
---|